 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
News Briefs Clinical Trials of Herpes Drug Are Halted on Preliminary DataFebruary 25, 2003 Eli Lilly & Co. and 3M Co. suspended clinical trials of their genital herpes treatment, Resiquimod, because preliminary data showed the drug was not as effective as expected. Lilly said the study's data showed no safety concerns with the drug, which showed positive results in earlier Phase II clinical trials. Lilly and 3M will evaluate the Phase III trial results, in addition to Phase II results, to determine whether to conduct further studies of Resiquimod. The drug is a more potent sister to 3M's Aldara, which also treats genital herpes. Separately, 3M said it will reevaluate the clinical approach on Resiquimod, while the company's broader family of immune-response-modifiers continues to show progress. A pipeline of new IRM molecules is being built by 3M for a broad range of indications.
Adapted from:Back to other CDC news for February 25, 2003 Wall Street Journal 02.25.03 This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
|
|
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Site Policies | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
